STEPHANIE NAUERT: Open Payments
NPI 1730427279 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 10 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $17 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $37 |
| Ardelyx, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $18 |
Products named: VEGZELMA, IBSRELA, XIFAXAN, ENTYVIO, RINVOQ, SKYRIZI, IQIRVO, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
